News

EU Commission releases "Assessment of the Supply Chain Vulnerabilities for the first Tranche of the Union List of critical Medicines"

On 10 July 2024 the European Commission's Health Emergency Preparedness and Response Authority (HERA) published a technical report evaluating vulnerabilities in the supply chain for medicines listed in the Union list of critical medicines.

More
Report on Trends in the Falsification of Medicines

The EU Commission published a report on the latest trends in the falsification of medicinal products. The report makes an attempt to include an assessment of whether the Falsified Medicines Directive is effective in preventing falsified medicines from entering the legal supply chain.

More
New Measures to Report Medicine Disappearances

The Council of Europe has adopted a new recommendation to report the disappearance of medicines. The aim is to protect public health by promoting better cooperation and reporting between the relevant authorities.

More
GDP Non-Compliance Report for Czech Wholesale Distributor

The competent authority of Czechia (State Institute for Drug Control) has issued a new GPD Non-Compliance Report - the first report published in the EudraGMDP database in 2024.

More
Templates for Shortage Prevention and Mitigation Plans issued by EMA

On 18th of June 2024, the EMA has issued templates for Shortage Prevention Plans (SPPs) and Shortage Mitigation Plans (SMPs). Marketing authorization holders in the European Union/European Economic Area are encouraged to create Shortage Prevention Plans to minimize the risk of medicinal shortages.

More
Checklist for Implementation of GDP Principles - Part 9: Transportation

According to Chapter 9 of the EU GDP Guidelines, it is the responsibility of the supplying wholesale distributor to protect medicinal products during transport. Regardless of the mode of transport, it should be possible to demonstrate that the medicines have not been exposed to conditions that may compromise their quality and integrity. In this article, you will find a checklist to verify the minimum implementation.

More
EU adopts Supply Chain Law - Implications for pharmaceutical Companies

On 24th of May 2024, the EU member states adopted the European Supply Chain Law which requires companies of a certain size to monitor and prevent negative impacts on human rights and the environment from their supply chain activities.

More
Serialization - Version 21 of the Q&As on Safety Features

The European Commission published a new version of the Questions & Answers (Q&As) regarding the safety features for medicinal products for human use. The new version contains four new Q&As compared to the previous version, which mainly cover the tasks of parallel traders when dealing with safety features during repackaging. 

More
Checklist for Implementation of GDP Principles - Part 8: Self-Inspections

According to Chapter 8 of the EU GDP Guidelines, self-inspections should be conducted in order to monitor implementation and compliance with GDP principles and to propose necessary corrective measures. In this article, you will find a checklist to verify the minimum implementation.

More
EMA publishes new Q&A Document on Remote RP Activities

The European Medicines Agency (EMA) has published a new Q&A document on Remote RP activities. Remote activities by the Responsible Person may be permitted, but should occur within the EU/EEA or Northern Ireland in all cases.

More
x
Search